ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 642915 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 642915; 2) Community: the network communities that were significantly associated with the response to NSC 642915; 3) Molecule: the relationships between components within communities and NSC 642915; 4) MDR: the compounds that were significantly associated with the NSC 642915.

NSC Compound Enrichment Correlation
NSC 647117 Null 0.0284045326811618 0.26301214
NSC 649307 Null 0.0284045326811618 0.29478718
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0284045326811618 0.63821624
NSC 667899 Null 0.0284045326811618 0.37698886
NSC 668476 Null 0.0284045326811618 0.3372184
NSC 676372 Null 0.0284045326811618 0.15904425
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0284045326811618 0.46386743
NSC 681636 Camptothecin Derivative 0.0284045326811618 0.64289753
NSC 683558 Camptothecin Derivative 0.0284045326811618 0.59809467
NSC 686940 Null 0.0284045326811618 0.059449628
Total:87  Current:51    [First] [Prev] [Next] [Last]